Discover how hepatologists, gastroenterologists, endocrinologists, and MASH specialists view the future of MASH care. This study analyzes unmet needs in diagnosis, confidence in non-invasive diagnostic tools, patient screening strategies, and factors influencing therapy adoption. The report provides valuable insights for pharmaceutical, biotech, and healthcare organizations seeking to understand the evolving treatment landscape.




